|
> Perhaps the most plausible possible cause identified so far is yet another compound identified by Diamond Shruumz itself. > In its recall notice, the company reported that third-party lab testing of some of its candies identified higher than normal amounts of muscimol, a psychoactive compound found in hallucinogenic Amanita mushrooms, including the iconic toadstool A. muscaria. > These mushrooms contain a combination of muscimol and the related ibotenic acid, both of which resemble neurotransmitters. > Together, they could cause the symptoms seen in the cases so far, including seizures, central nervous system depression (loss of consciousness, confusion, sleepiness), agitation, abnormal heart rates, hyper/hypotension, nausea, and vomiting. And in pharmaceutical manufacturing, diluting things is definitely a science. Gotta worry about demixing, adsorption, absorption, granulations, cracking or creaming of emulsions (if present), caking... lots of fun when you need to make something consistent at low concentrations. |